1. Home
  2. KNSA vs CVI Comparison

KNSA vs CVI Comparison

Compare KNSA & CVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • CVI
  • Stock Information
  • Founded
  • KNSA 2015
  • CVI 1906
  • Country
  • KNSA United Kingdom
  • CVI United States
  • Employees
  • KNSA N/A
  • CVI N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • CVI Integrated oil Companies
  • Sector
  • KNSA Health Care
  • CVI Energy
  • Exchange
  • KNSA Nasdaq
  • CVI Nasdaq
  • Market Cap
  • KNSA 1.9B
  • CVI 1.8B
  • IPO Year
  • KNSA 2018
  • CVI 2007
  • Fundamental
  • Price
  • KNSA $27.36
  • CVI $23.39
  • Analyst Decision
  • KNSA Strong Buy
  • CVI Sell
  • Analyst Count
  • KNSA 5
  • CVI 5
  • Target Price
  • KNSA $38.80
  • CVI $23.00
  • AVG Volume (30 Days)
  • KNSA 474.9K
  • CVI 991.6K
  • Earning Date
  • KNSA 07-22-2025
  • CVI 04-28-2025
  • Dividend Yield
  • KNSA N/A
  • CVI 11.80%
  • EPS Growth
  • KNSA N/A
  • CVI N/A
  • EPS
  • KNSA N/A
  • CVI N/A
  • Revenue
  • KNSA $481,166,000.00
  • CVI $7,393,000,000.00
  • Revenue This Year
  • KNSA $37.21
  • CVI $0.60
  • Revenue Next Year
  • KNSA $5.32
  • CVI $7.88
  • P/E Ratio
  • KNSA N/A
  • CVI N/A
  • Revenue Growth
  • KNSA 59.45
  • CVI N/A
  • 52 Week Low
  • KNSA $17.38
  • CVI $15.10
  • 52 Week High
  • KNSA $28.56
  • CVI $29.84
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 62.48
  • CVI 59.80
  • Support Level
  • KNSA $26.28
  • CVI $22.93
  • Resistance Level
  • KNSA $27.90
  • CVI $24.13
  • Average True Range (ATR)
  • KNSA 0.99
  • CVI 0.95
  • MACD
  • KNSA -0.07
  • CVI -0.08
  • Stochastic Oscillator
  • KNSA 82.30
  • CVI 57.30

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About CVI CVR Energy Inc.

CVR Energy Inc is a holding company that engages in petroleum refining and nitrogen fertilizer manufacturing through its subsidiaries. Subsidiaries include several complex, full-coking crude oil refineries, along with a crude oil gathering system, pipelines and storage tanks, and marketing and supply. The company's refineries can process blends of a variety of crude oil ranging from heavy sour to light sweet crude oil. Crude oil for CVR's refineries is supplied through its wholly-owned gathering system and pipeline. From its refineries, CVR supplies products through tanker trucks directly to customers located in close geographic proximity and customers at throughput terminals. The company's customers include retailers, railroads, and farm cooperatives.

Share on Social Networks: